These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11502303)

  • 1. A randomized trial of interferon-alpha in cervical dysplasia.
    Gostout BS; Hartmann LC; Suman VJ; Fay NE; Jefferies JA; Morton RF; Gaffey TA; Farr GH; Tschetter LK; Abu-Ghazaleh S; Gallenberg MM; Hatfield AK
    Int J Gynaecol Obstet; 2001 Aug; 74(2):207-10. PubMed ID: 11502303
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful pregnancy after vaginal cancer treated with interferon.
    Murta EF; Tavares Murta BM
    Tumori; 2004; 90(2):247-8. PubMed ID: 15237591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The viral and bacterial nature of dysplasia and of cervical carcinoma].
    Afanas'ev MS; Aleshkin VA; Afanas'ev SS; Levakov SA; Vorob'ev AA; Sidorova IS; Nesvizhskiĭ IuV
    Vestn Ross Akad Med Nauk; 2004; (6):35-40. PubMed ID: 15327060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical dysplasia regression induced by all-trans-retinoic acid.
    Sporn MB; Roberts AB
    J Natl Cancer Inst; 1994 Apr; 86(7):476-7. PubMed ID: 8133526
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence re: M. Follen et al., a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
    Formelli F
    Clin Cancer Res; 2002 May; 8(5):1310-2; author reply 1313. PubMed ID: 12006553
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of dysplasia of the cervical epithelium with an interferon gel.
    Møller BR; Johannesen P; Osther K; Ulmsteen U; Hastrup J; Berg K
    Obstet Gynecol; 1983 Nov; 62(5):625-9. PubMed ID: 6353302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant interferon: extended follow-up times needed?
    Thoren FB; Strannegård Ö
    Lancet Oncol; 2011 May; 12(5):419. PubMed ID: 21536217
    [No Abstract]   [Full Text] [Related]  

  • 8. [The experimental and clinical antitumor action of the interferon inducer larifan].
    Gasparian MG; Dzhagatspanian NG; Gevorkian RA; Kamalian LA
    Vopr Virusol; 1991; 36(2):127-30. PubMed ID: 1909072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with topical tretinoin in the treatment of cervical dysplasia.
    Meyskens FL; Surwit ES
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):826-9. PubMed ID: 3534021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cervical dysplasia with bromocriptine.
    Donath EM; Schindler AE
    Lancet; 1984 Jul; 2(8395):157. PubMed ID: 6146049
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon treatment for corneolimbal squamous dysplasia.
    Hu FR; Wu MJ; Kuo SH
    Am J Ophthalmol; 1998 Jan; 125(1):118-9. PubMed ID: 9437331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia.
    Farley JH; Truong V; Goo E; Uyehara C; Belnap C; Larsen WI
    Gynecol Oncol; 2006 Nov; 103(2):425-30. PubMed ID: 16677697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ukrain treatment in carcinoma of the cervix (case report).
    Kroiss T; Melnyk A; Korsh OB
    Drugs Exp Clin Res; 1996; 22(3-5):255-7. PubMed ID: 8899342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer agents. Cream reduces reappearance of cervical lesions.
    TreatmentUpdate; 2000 Feb; 12(1):5-6. PubMed ID: 12125629
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cervical intraepithelial neoplasia associated with HSV2. Treatment with human beta interferon].
    Perri D
    Minerva Ginecol; 1992; 44(1-2):39-41. PubMed ID: 1324444
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.
    Clavio M; Masoudi B; Spriano M; Casciaro S; Gobbi M; Damasio EE
    Haematologica; 1999 May; 84(5):466-8. PubMed ID: 10329930
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
    Suh-Burgmann E; Sivret J; Duska LR; Del Carmen M; Seiden MV
    Gynecol Obstet Invest; 2003; 55(1):25-31. PubMed ID: 12624548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid and vitamin C in cervical dysplasia.
    Butterworth CE; Norris D
    Am J Clin Nutr; 1983 Feb; 37(2):332-3. PubMed ID: 6823899
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results.
    Cunningham D; Powles R; Malpas J; Raje N; Milan S; Viner C; Montes A; Hickish T; Nicolson M; Johnson P; Treleaven J; Raymond J; Gore M
    Br J Haematol; 1998 Jul; 102(2):495-502. PubMed ID: 9695964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.
    Butterworth CE; Hatch KD; Gore H; Mueller H; Krumdieck CL
    Am J Clin Nutr; 1982 Jan; 35(1):73-82. PubMed ID: 7064879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.